A Randomized, Double-Blinded Controlled Trial Comparing High vs Standard Dose Oseltamivir in Severe, Influenza Infection in ICU. "ROSII Study".

Trial Profile

A Randomized, Double-Blinded Controlled Trial Comparing High vs Standard Dose Oseltamivir in Severe, Influenza Infection in ICU. "ROSII Study".

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Sep 2013

At a glance

  • Drugs Oseltamivir (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Biomarker; Therapeutic Use
  • Acronyms ROSII
  • Most Recent Events

    • 12 Sep 2013 Results presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy.
    • 12 Sep 2013 Primary endpoint 'Viral-load' has been met.
    • 05 May 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top